Award recordCONTRACT

ORIGENE TECHNOLOGIES, INC.

PIID VA662D10234· VHA· 261-NETWORK CONTRACT OFFICE 21· 6505 · DRUGS AND BIOLOGICALS· FY2011· $11,040 net obligations· UEI J6D6NR41SF54· MD

Description

TO PROCURE TISSUE QPCR PLATES NECESSARY TO DETERMINE EXPRESSION LEVELS OF VARIOUS BIOMAKERS IN CANCEROUS AND NORMAL TISSUE SAMPLES LIKE KIDNEY CANCER TISSUE QPCR AND PROSTATE CANCER TISSUE QPCR.

First action · last action
2011-08-26 · 2011-09-18
Transactions
2
First transaction's obligation
$11,030
Base + all options value (sum of deltas)
$11,040
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$11,040$0Base award · 2011-08-26 · this action $11,030 · running total $11,030Modification 1 · 2011-09-18 · this action $10 · running total $11,040
  • Base2011-08-26+$11,030= $11,030
  • Mod 12011-09-18+$10= $11,040
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2011-08-26+$11,030$11,030TO PROCURE TISSUE QPCR PLATES NECESSARY TO DETERMINE EXPRESSION LEVELS OF VARIOUS BIOMAKERS IN CANCEROUS AND N…
Mod 1· FUNDING ONLY ACTION2011-09-18+$10$11,040TO PROCURE TISSUE QPCR PLATES NECESSARY TO DETERMINE EXPRESSION LEVELS OF VARIOUS BIOMAKERS IN CANCEROUS AND N…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI J6D6NR41SF54)

AwardOffice · PSC / listingNet obligationsFY
36C24E23P0098RPO EAST (36C24E) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH$76,045FY2023
36C24223P0943242-NETWORK CONTRACT OFFICE 02 (36C242) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH$27,407FY2023
VA24115P2024241-NETWORK CONTRACT OFFICE 01 (36C241) · 6810 · CHEMICALS$0FY2015
VA25112P1002553-DETROIT · 6505 · DRUGS AND BIOLOGICALS$6,000FY2012
VA603D10022249-NETWORK CONTRACT OFFICE 9 · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$9,168FY2011
VA662D10233261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS$13,807FY2011

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26116F1413CSL BEHRING L.L.C.261-NETWORK CONTRACT OFFICE 21$12,789FY2016
VA26116F1408CSL BEHRING L.L.C.261-NETWORK CONTRACT OFFICE 21$10,733FY2016
VA26116F1244SEQIRUS USA INC261-NETWORK CONTRACT OFFICE 21$31,450FY2016
VA26116F1240SEQIRUS USA INC261-NETWORK CONTRACT OFFICE 21$7,234FY2016
VA26116F1213SEQIRUS USA INC261-NETWORK CONTRACT OFFICE 21$62,900FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA662D10234_3600_-NONE-_-NONE- · retrieved 2026-09-26.